# A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy

> **NCT01955824** · PHASE2,PHASE3 · COMPLETED · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 500 (actual)

## Conditions studied

- Lung Cancer
- Tuberculosis
- Sarcoidosis
- Interstitial Lung Disease

## Interventions

- **DRUG:** 1% lignocaine
- **DRUG:** 2% lignocaine

## Key facts

- **NCT ID:** NCT01955824
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01955824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01955824, "A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01955824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*